BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 6426923)

  • 1. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
    Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auranofin.
    Davis P
    Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action, pharmacology, clinical efficacy and side effects of auranofin. An orally administered organic gold compound for the treatment of rheumatoid arthritis.
    Furst DE
    Pharmacotherapy; 1983; 3(5):284-98. PubMed ID: 6417628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
    Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
    [No Abstract]   [Full Text] [Related]  

  • 6. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
    Batlle Gualda E
    Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative safety and efficacy of auranofin and parenteral gold compounds: a review.
    Horton RJ
    Scand J Rheumatol Suppl; 1983; 51():100-10. PubMed ID: 6426044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auranofin: a unique oral chrysotherapeutic agent.
    Blodgett RC; Heuer MA; Pietrusko RG
    Semin Arthritis Rheum; 1984 Feb; 13(3):255-73. PubMed ID: 6427927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study.
    Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H
    J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of auranofin, an oral chrysotherapeutic agent.
    Delafuente JC; Osborn TG
    Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multicenter double-blind comparison of auranofin and Tauredon].
    Kaik B; Bröll H
    Wien Klin Wochenschr Suppl; 1984; 156():33-40. PubMed ID: 6442055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of oral and parenteral gold therapy--review of the literature].
    Thumb N
    Wien Klin Wochenschr Suppl; 1984; 156():44-8. PubMed ID: 6442057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
    Davis P; Menard H; Thompson J; Harth M; Beaudet F
    J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auranofin: experience to date.
    Blodgett RC
    Am J Med; 1983 Dec; 75(6A):86-9. PubMed ID: 6419601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placebo-controlled comparison of oral gold with injectable gold in early rheumatoid arthritis.
    Davies J; Bacon PA; Hall ND; Ring EF
    Clin Rheumatol; 1984 Dec; 3(4):553-4. PubMed ID: 6441670
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences to date with oral gold therapy].
    Zeidler H
    Wien Klin Wochenschr Suppl; 1984; 156():22-7. PubMed ID: 6442052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacological profile of auranofin, an orally active gold compound.
    Walz DT; DiMartino MJ; Griswold DE
    Scand J Rheumatol Suppl; 1983; 51():16-25. PubMed ID: 6426049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral chrysotherapy in rheumatoid arthritis: auranofin. Cleveland Clinic experience and literature review.
    Mazanec DJ; Segal AM; Mackenzie AH; Lippert M
    Cleve Clin Q; 1985; 52(2):123-8. PubMed ID: 3928200
    [No Abstract]   [Full Text] [Related]  

  • 20. Auranofin therapy in rheumatoid arthritis.
    Bernhard GC
    J Lab Clin Med; 1982 Aug; 100(2):167-77. PubMed ID: 6808066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.